Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.54 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8843690 | 0.89 | SMN1; SMN2 (0.73) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL2317454 | 0.87 | RXRA (0.61) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| Hydrochloric Acid SCHEMBL16143333 | 0.85 | RXRA (0.60) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL10429197 | 0.84 | GLRA1 (0.64) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL5240840 | 0.84 | HPGD (0.74) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL15673277 | 0.84 | RXRA (0.62) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL7082122 | 0.84 | KDM4E (0.64) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL9680615 | 0.83 | HPGD (0.58) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| Hydrochloric Acid SCHEMBL31692073 | 0.83 | KDM4E (0.63) | HPGDNPC1RAB9ASMN1; SMN2SLC6A5 | |
| SCHEMBL10998628 | 0.82 | CTSV (0.49) | HPGDNPC1RAB9ASMN1; SMN2SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9359346-B2 | Benzamide derivative and use thereof | VIVOZON, INC. (KR) | 2016-06-07 | — | — | US | disclosed |
| US-20140336378-A1 | NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF | VIVOZON, INC. (KR) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140336378-A1 | NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF | TRPV1, TRPA1, TRPV5 | HPGD 1066/4885NPC1 783/4885RAB9A 1568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.